Premier Asset Management LLC Acadia Pharmaceuticals Inc Transaction History

Premier Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $661,443 - $934,884	-34,095 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$25.02 - $54.99 $853,056 - $1.87 Million	34,095 New	34,095 $879,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $337,307 - $466,757	-8,219 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $299,335 - $468,483	8,219 New	8,219 $339,000
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $288,957 - $489,280	-17,870 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$14.32 - $22.92 $255,898 - $409,580	17,870 New	17,870 $293,000

316

164M

855K

350K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.